The video shows the NIBRT Training Team in the pilot plant, as they detail the step-by-step manufacturing processes for the production of biotherapeutics. The National Institute for Bioprocessing Research and Training (NIBRT) replicates a modern bioprocessing plant with state-of-the-art equipment for the production and analysis of biopharmaceuticals, such as therapeutic monoclonal antibodies (mABs). The video shows the NIBRT Training Team in the pilot plant, as they detail the step-by-step manufacturing processes for the production of biotherapeutics. This is followed by a summary of the analytical technologies used by the NIBRT Glycobiology Research Group to analyse the sugars or “glycans” present on the biopharmaceuticals.